METHOD OF PRODUCING CALCIUM SALT (E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROYL-2-[METHYL(METHYSUFONYL)AMINO]PYRIMIDIN-5-YL](3R,5S)3,5-DIHYDROXYHEPT-6-ENOIC ACID (ROSUVASTATIN CALCIUM SALT) Russian patent published in 2009 - IPC C07D239/42 

Abstract RU 2361864 C2

FIELD: chemistry.

SUBSTANCE: invention relates to an improved method of producing calcium salt (E)-7[4(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid (rosuvastatin calcium salt), suitable for making a pharmaceutical drug, useful in treatment of, among others, hypercholesteremia, hyperlipoproteinemia and atherosclerosis. The method involves stages (a)-(g): a) reaction of (1-6C)alkyl ester (E)-(6-{2-[4-(4-flurophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4R,6S)-2,2-dimethyl[1,3]dioxin-4-yl)acetic acid in an organic solvent mixed with water with aqua acid at high temperature; b) reaction of the obtained solution with aqueous hydroxide of an alkali metal and, possibily, washing the obtained aqueous solution of salt of the alkali metal with a suitable organic solvent; c) bringing the pH of the obtained solution to approximately pH 9-10.5 by adding aqueous hydrochloric acid; d) removal of the organic solvent mixed with water; e) possible filtration of the obtained mixture; f) addition of water soluble calcium salt to the filtrate so that, calcium salt (E)-7[4(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(1R,5S)-3,5-dihydroxyhept-6-enoic acid is formed; and g) extraction of product of stage (f). The preferred organic solvent mixed with water is acetonitrile. Aqua acid on stage (a) is hydrochloric acid. Stage (b) involves reaction of the obtained solution with aqueous sodium hydroxide and washing the obtained aqueous solution of sodium salt with a suitable hydrocarbon, ester or ether solvent, for example, toluene, xylol, MTBE (methyl-tert-butyl ether) or ethyl acetate.

EFFECT: improved method.

Similar patents RU2361864C2

Title Year Author Number
METHOD OF ROSUVASTATIN CALCIUM SALT PREPARATION 2003
  • Khorberi Dzhon
  • Tejlor Najdzhel Filip
RU2326871C2
METHOD OF PRODUCING ROSUVASTATIN CALCIUM SALT (E) -7-[4-(4-FLUOROPHEHYL)-6-ISOPROPYL-2-[METHYL(METHYLSULPHONYL)AMINO]PYRIMIDIN-5-YL](3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID AND CRYSTALLINE INTERMEDIATE PRODUCTS THEREOF 2004
  • Okada Tetsuo
  • Khorberi Dzhon
  • Laffan Dejvid Dermot Patrik
RU2372349C2
CRYSTALLINE FORM OF CALCIUM SALT OF BIS-[(E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULPHONYL)AMINO]-PYRIMIDIN-5-YL](3R, 5S)-3, 5-DIHYDROXYHEPT-6-ENOIC ACID 2004
  • But Rebekka Dzhejn
  • Sittern Piter Ehntoni
  • Krabb Dzheffri Norman
  • Khorberi Dzhon
  • Dzhouns Dejvid Uin Kalvert
RU2363697C2
7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2- [METHYL(METHYLSULFONYL)AMINO]PYRIMIDIN -5-YL]-(3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID CRYSTALLINE SALTS, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION 2001
  • Tehjlor Najdzhel Filip
  • Okada Tetsuo
RU2265599C2
TERTIARY BUTYL-(E)-(6-{2-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO]-PYRIMIDINE-5-YL}-(4R,6S)-2,2-DIMETHYL[1,3]DIOXANE-4-YL]ACETATE AND METHOD FOR ITS PREPARING, DIPHENYL-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO]-PYRIMIDINE-5-YLMETHYL]PHOSPHINE OXIDE, METHODS FOR PREPARING (E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO]-PYRIMIDINE-5-YL]-(3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID AND ITS DERIVATIVES 2000
  • Koike Kharuo
  • Kabaki Mikio
  • Tehjlor Najdzhel Filip
  • Dioratsio Lui Dzhozef
RU2243969C2
PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITOR OF HMG-REDUCTASE 2000
  • Krikmor Dzhozef Richard
  • Uigginz Norman Al'Fred
RU2206324C1
CRYSTALLINE HYDRATED FORM OF BIS-[(E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO]-PYRIMIDINE-5-YL]-(3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID] CALCIUM SALT, METHOD FOR ITS PREPARING, PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PREPARING AND METHOD FOR TREATMENT 1999
  • Tejlor Najdzhel Fillip
RU2236404C2
APPLICATION OF ROSUVASTATIN (ZD-4522) IN TREATING HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA 2001
  • Rehjza Ali
  • Khatchinson Khauard Dzherard
RU2294744C2
PHARMACEUTICAL COMPOSITION COMPRISING INHIBITOR OF HMG-COA- REDUCTASE 2000
  • Krikmor Dzhozef Richard
  • Vidzhins Norman Alfred
RU2264210C2
APPLICATION OF 3-HYDROXY-3-METHTYLGLUTARYL-COENZYME A REDUCTASE INHIBITORS IN PRODUCING MEDICINAL AGENT FOR TREATMENT OF DIABETIC NEUROPATHY 2000
  • Kehmeron Norman Judzhin
  • Kotter Mehri Ehnn
RU2239456C2

RU 2 361 864 C2

Authors

Krabb Dzheffri Norman

Khorberi Dzhon

Tejlor Najdzhel Filip

Dates

2009-07-20Published

2004-06-03Filed